Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 27,900 shares, an increase of 59.4% from the December 15th total of 17,500 shares. Currently, 0.4% of the company’s shares are short sold. Based on an average daily volume of 42,300 shares, the short-interest ratio is presently 0.7 days.

Cocrystal Pharma Trading Down 2.0 %

NASDAQ:COCP traded down $0.04 during trading hours on Friday, hitting $1.97. 21,713 shares of the company were exchanged, compared to its average volume of 45,319. The stock has a market capitalization of $20.03 million, a price-to-earnings ratio of -1.06 and a beta of 1.53. Cocrystal Pharma has a one year low of $1.33 and a one year high of $3.26. The company has a fifty day simple moving average of $2.15 and a 200 day simple moving average of $2.00.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.